| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 901 | 2017 |
| Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia O Agid, B Shapira, J Zislin, M Ritsner, B Hanin, H Murad, T Troudart, ... Molecular psychiatry 4 (2), 163-172, 1999 | 838 | 1999 |
| Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected O Agid, S Kapur, T Arenovich, RB Zipursky Archives of general psychiatry 60 (12), 1228-1235, 2003 | 551 | 2003 |
| Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders G Foussias, O Agid, G Fervaha, G Remington European Neuropsychopharmacology 24 (5), 693-709, 2014 | 271 | 2014 |
| An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis O Agid, T Arenovich, G Sajeev, RB Zipursky, S Kapur, G Foussias, ... Journal of Clinical Psychiatry 72 (11), 1439, 2011 | 265 | 2011 |
| Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia G Fervaha, G Foussias, O Agid, G Remington Acta Psychiatrica Scandinavica 130 (4), 290-299, 2014 | 261 | 2014 |
| Environmental stress and psychiatric illness O Agid, Y Kohn, B Lerer Biomedicine & pharmacotherapy 54 (3), 135-141, 2000 | 252 | 2000 |
| The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research SG Potkin, JM Kane, CU Correll, JP Lindenmayer, O Agid, SR Marder, ... NPJ schizophrenia 6 (1), 1, 2020 | 241 | 2020 |
| Clinical guidance on the identification and management of treatment-resistant schizophrenia JM Kane, O Agid, ML Baldwin, O Howes, JP Lindenmayer, S Marder, ... The Journal of clinical psychiatry 80 (2), 2783, 2019 | 239 | 2019 |
| Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making G Fervaha, A Graff-Guerrero, KK Zakzanis, G Foussias, O Agid, ... Journal of psychiatric research 47 (11), 1590-1596, 2013 | 237 | 2013 |
| Evidence for onset of antipsychotic effects within the first 24 hours of treatment S Kapur, T Arenovich, O Agid, R Zipursky, S Lindborg, B Jones American Journal of Psychiatry 162 (5), 939-946, 2005 | 237 | 2005 |
| Impact of primary negative symptoms on functional outcomes in schizophrenia G Fervaha, G Foussias, O Agid, G Remington European Psychiatry 29 (7), 449-455, 2014 | 228 | 2014 |
| Treating negative symptoms in schizophrenia: an update G Remington, G Foussias, G Fervaha, O Agid, H Takeuchi, J Lee, M Hahn Current treatment options in psychiatry 3, 133-150, 2016 | 203 | 2016 |
| Equivalent Occupancy of Dopamine D1 and D2 Receptors With Clozapine: Differentiation From Other Atypical Antipsychotics J Tauscher, T Hussain, O Agid, NPLG Verhoeff, AA Wilson, S Houle, ... American Journal of Psychiatry 161 (9), 1620-1625, 2004 | 201 | 2004 |
| Adverse Subjective Experience With Antipsychotics and Its Relationship to Striatal and Extrastriatal D 2 Receptors: a PET Study in Schizophrenia R Mizrahi, P Rusjan, O Agid, A Graff, DC Mamo, RB Zipursky, S Kapur American Journal of Psychiatry 164 (4), 630-637, 2007 | 193 | 2007 |
| Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome G Fervaha, G Foussias, O Agid, G Remington Schizophrenia research 166 (1-3), 9-16, 2015 | 183 | 2015 |
| Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits G Foussias, S Mann, KK Zakzanis, R Van Reekum, O Agid, G Remington Schizophrenia research 132 (1), 24-27, 2011 | 171 | 2011 |
| Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response—a double-blind PET study in schizophrenia O Agid, D Mamo, N Ginovart, I Vitcu, AA Wilson, RB Zipursky, S Kapur Neuropsychopharmacology 32 (6), 1209-1215, 2007 | 171 | 2007 |
| Meta-regression analysis of placebo response in antipsychotic trials, 1970–2010 O Agid, CO Siu, SG Potkin, S Kapur, E Watsky, D Vanderburg, ... American Journal of Psychiatry 170 (11), 1335-1344, 2013 | 160 | 2013 |
| Does relapse contribute to treatment resistance? Antipsychotic response in first-vs. second-episode schizophrenia H Takeuchi, C Siu, G Remington, G Fervaha, RB Zipursky, G Foussias, ... Neuropsychopharmacology 44 (6), 1036-1042, 2019 | 159 | 2019 |
